and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
The executive who transformed the pharmaceuticals company then known as Glaxo into a global industry leader